Ranitidine Therapy for Gastroesophageal Reflux Disease: Results of a Large Double-blind Trial

Archives of Internal Medicine

Volumn 147, Issue 8, 1987, Pages 1485-1491

  Sontag, Stephen ^a,c   Robinson, Malcolm ^a   McCallum, Richard W ^a   Barwick, Kenneth W ^a   Nardi, Ronald ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GLAXOSMITHKLINE   (United States)

^c Section of Gastroenterology Yale University School of Medicine ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; RANITIDINE;

CLINICAL ARTICLE; DRUG EFFICACY; ESOPHAGUS; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; MANOMETRY; PRIORITY JOURNAL; THERAPY;

ADULT; ANTACIDS; CLINICAL TRIALS; DOUBLE-BLIND METHOD; ESOPHAGITIS, PEPTIC; ESOPHAGUS; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMANS; RANDOM ALLOCATION; RANITIDINE;

EID: 84942005158     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.1987.00370080123022     Document Type: Article

References (34)

1. 1. Graham DY, Smith JL, Patterson DJ: Why do apparently healthy people use antacid tablets? Am J Gastroenterol 1983;78:257-260.
2. 2. Nebel OT, Forbes MF, Castell DO: Symptomatic gastroesophageal reflux: Incidence and precipitating factors. Am J Dig Dis 1976;21:953-956.
3. 3. Johnson LF, DeMeester TR: Twenty-four-hour pH monitoring of the distal esophagus: A quantitative measure of gastroesophageal reflux. Am J Gastroenterol 1974;62:325-352.
4. 4. Dent J, Dodds WJ, Friedman RH, et al: Mechanism of gastroesophageal reflux in recumbent asymptomatic human subjects. J Clin Invest 1980;65:256-267.
5. 5. Dodds WJ, Dent J, Hogan WJ, et al: Mechanisms of gastroesophageal reflux in patients with reflux esophagitis. N Engl J Med 1982;307: 1547-1552.
6. 6. Stanciu C, Bennett JR: Oesophageal acid clearing: One factor in the production of reflux oesophagitis. Gut 1974;15:852-857.
7. 7. Orr WC, Robinson MG, Johnson LF: Acid clearance during sleep in the pathogenesis of reflux esophagitis. Dig Dis Sci 1981;26:423-427.
8. 8. McCallum RW, Berkowitz DM, Lerner E: Gastric emptying in patients with gastroesophageal reflux. Gastroenterology 1981;80:285-291.
9. 9. Holloway RH, Hongo M, Berger K, et al: Gastric distention: A mechanism for postprandial gastroesophageal reflux. Gastroenterology 1985;89:779-784.
10. 10. McCallum RW, Mensh R, Lange R: Definition of the gastric emptying abnormality present in gastroesophageal reflux patients, in Wienbeck M (ed): Motility of the Digestive Tract. New York, Raven Press, 1982.
11. 11. McCallum RW, Holloway RH, Callachan C, et al: Endogenous gastrin release and antral gastrin concentration in gastroesophageal reflux patients and normal subjects. Am J Gastroenterol 1983;78:398-402.
12. 12. Holloway RH, McCallum RW: A practical approach to gastroesophageal reflux. Drug Ther 1983;13:151-160.
13. 13. Castell DO: Medical therapy of reflux esophagitis. Ann Intern Med 1980;93:926-927.
14. 14. Richter JE: Gastroesophageal reflux disease: A review of medical therapy, in Castell DO, Wu WC, Ott DJ (eds): Gastroesophageal Reflux Disease: Pathogenesis, Diagnosis, Therapy. Mount Kisco, NY, Futura Publishing Co, 1985, pp 221-241.
15. 15. Behar J, Brand DL, Brown FC, et al: Cimetidine in the treatment of symptomatic gastroesophageal reflux: A double-blind controlled trial. Gastroenterology 1978;74:441-448.
16. 16. Wesdorp E, Bartelsman J, Pape K, et al: Oral cimetidine in reflux esophagitis: A double-blind controlled trial. Gastroenterology 1978;74: 821-824.
17. 17. Powell-Jackson P, Barkiey H, Northfield TC: Effect of cimetidine in symptomatic gastroesophageal reflux. Lancet 1978;2:1068.
18. 18. Fiasse R, Hanin C, Lepot A, et al: Controlled trial of cimetidine in reflux esophagitis. Dig Dis Sci 1980;25:750-755.
19. 19. Brater DC, Peters MN, Eshelman FN, et al: Clinical comparison of cimetidine and ranitidine. Clin Pharmacol Ther 1982;32:484-489.
20. 20. Holloway RH, Kuljian B, Eshelman F, et al: Effects of ranitidine and of cimetidine on pentagastrin-stimulated gastric acid secretion. Clin Pharmacol Ther 1982;35:203-207.
21. 21. Ismail-Beigi F, Horton PF, Pope CE: Histological consequences of gastroesophageal reflux in man. Gastroenterology 1970;58:163-174.
22. 22. Kobayashi S, Kasugai T: Endoscopic and biopsy criteria for the diagnosis of esophagitis with a fiberoptic esophagoscope. Am J Dig Dis 1974;19:345-352.
23. 23. Fink SM, Barwick KW, Winchenbach CL, et al: Reassessment of esophageal histology in normal subjects: A comparison of suction and endoscopic techniques. J Clin Gastroenterol 1983;5:177-183.
24. 24. Bernstein LM, Baker LA: A clinical test for esophagitis. Gastroenterology 1958;34:760-781.
25. 25. Van Elteren PH: On the combination of independent two-sample tests of Wilcoxon. Bull Inst Intern Statist 1960;37:351-361.
26. 26. Lehmann EL: Nonparametrics: Statistical Methods Based on Ranks. Oakland, Calif, Holden-Day Inc, 1975, pp 132-145.
27. 27. Hirschowitz BI: Lessons from the US multicenter trial of ranitidine treatment of duodenal ulcer. J Clin Gastroenterol 1983;5(suppl 1):115-122.
28. 28. Graham DY, Lanza F, Dorsch ER: Symptomatic reflux esophagitis: A double-blind controlled comparison of antacids and alginate. Curr Ther Res 1977;22:653-658.
29. 29. Graham DY, Patterson DJ: Double-blind comparison of liquid antacid and placebo in the treatment of symptomatic reflux esophagitis. Dig Dis Sci 1983;28:559-563.
30. 30. Meyer C, Berenweig H, Kuljian B, et al: Controlled trial of antacid (AA) versus placebo (P) on relief of heartburn. Gastroenterology 1979;76: 1201.
31. 31. Domschke W, Lux G, Domschke S: Furan H2-antagonist, ranitidine, inhibits pentagastrin-stimulated acid secretion stronger than cimetidine. Gastroenterology 1980;79:1267-1271.
32. 32. Kett K, Aadland E, Berstad A: Inhibition of gastric secretion in man with a new H2-receptor antagonist, ranitidine. Scand J Gastroenterol 1980;15:249-251.
33. 33. Sewing K-FR, Billian A, Malchow H: Comparative study with ranitidine and cimetidine on gastric acid secretion in normal volunteers. Gut 1980;21:750-752.
34. 34. Fink M, McCallum RW: The role of prolonged esophageal pH monitoring in the diagnosis of gastroesophageal reflux. JAMA 1984;252: 1160-1164.